Generate Biomedicines

Lead clinical science for Phase 2 and 3 respiratory trials, focusing on asthma and COPD. Drive the development of protocols, regulatory documents, and oversee day-to-day study execution and data quality.

The Vice President will lead the Respiratory Product Strategy Team to design and deliver late-stage clinical programs for asthma and COPD. They are responsible for building a high-performing team, overseeing global clinical trials, and managing regulatory interactions and safety profiles.